公开(公告)号：JPH0368597A

公开(公告)日：1991-03-25

申请号：JP17428790

申请日：1990-06-30

Applicant: ABBOTT LAB

Inventor： KAZUMI SHIOSAKI ,  ARETSUKUSU EMU NADOZAN ,  DEBITSUDO ESU GAABEI ,  YUU-KON SHIYUU ,  MAAKU ESU BURODEII ,  MAAKU DABURIYU HORADEI ,  JIYON WAIIERU CHIYAN ,  MAIKERU DEII CHIYUFUANO ,  POORU DEII MEI

IPC: C07D487/04 ,  A61K38/00 ,  A61P1/00 ,  A61P9/00 ,  A61P11/00 ,  A61P25/00 ,  A61P25/28 ,  A61P25/30 ,  A61P39/02 ,  C07K1/06 ,  C07K5/02 ,  C07K5/06 ,  C07K5/08 ,  C07K5/083 ,  C07K5/10 ,  C07K5/107 ,  C07K5/117

公开(公告)号：JPH0355057A

公开(公告)日：1991-03-08

申请号：JP8731590

申请日：1990-03-30

Applicant: ABBOTT LAB

Inventor： JIEIMUZU EFU MITSUDOO ,  RICHIYAADO DABURIYUU GURABENKO ,  EDOWAADO ESU TORITSUPU ,  PIITAA ERU BURAIANTO ,  TEIMOSUII JIEI OSUWARUDO

IPC: A61G9/00 ,  A61F5/44 ,  A61F5/441 ,  A61F5/451 ,  A61L2/16 ,  A61M1/00

Abstract: PURPOSE: To keep chances of infection by infections pathogesis to a minimum by having improved valves, a multi-stack container transfer system and a lock mechanism of the top on elastic liner and by sprinkling waste treatment agent in a closed reservoir tank. CONSTITUTION: A valve 38 is applied in the channel leading to a closed room 16 from an inlet tube 26. The valve 38 serves to conduct is one direction only of the flow of the waste sucked into the close room 16 from a waste source. The close room surrounds the whole of a reservoir tank 40 which is normally closed, and the reservoir tank houses waste treatment agent inside as far as it is closed. The waste treatment agent is sprinkled in the close room 16 when the reservoir tank 40 is opened on taking off a closure member 42. Operation of this system is visually checked as the plug 50, made of low density material such as cork, and put detachably onto the opening of a tube 46 float on the waste treatment agent.

公开(公告)号：JPH02283299A

公开(公告)日：1990-11-20

申请号：JP6550190

申请日：1990-03-15

Applicant: ABBOTT LAB

Inventor： MAIKERU EDOWAADO MAKUMAHON ,  JIYURIAN GOODON

IPC: C12M1/00 ,  C12Q1/68 ,  C12Q1/6834 ,  C12Q1/6876 ,  C12Q1/689 ,  C12Q1/70

公开(公告)号：JPH02261395A

公开(公告)日：1990-10-24

申请号：JP2499990

申请日：1990-02-02

Applicant: ABBOTT LAB

Inventor： GURAJIMIIRU JII JIYOOJIBITSUCH

IPC: G01N30/90 ,  C12Q1/00 ,  C12Q1/28 ,  C12Q1/34 ,  C12Q1/42 ,  C12Q1/44 ,  G01N33/558

公开(公告)号：JPH02247157A

公开(公告)日：1990-10-02

申请号：JP1343390

申请日：1990-01-23

Applicant: ABBOTT LAB

Inventor： ROBAATO II DABURAA ,  SUUZAN EI TATSUKAA ,  JIYON EI UOORINGU ,  NAIII WAN

IPC: G01N33/53 ,  C07C49/215 ,  C07C59/84 ,  C07C225/16 ,  C07C235/70 ,  C07C237/04 ,  G01N33/533 ,  G01N33/542 ,  G01N33/94

公开(公告)号：JPH02218691A

公开(公告)日：1990-08-31

申请号：JP26605689

申请日：1989-10-11

Applicant: ABBOTT LAB

Inventor： KURISUTOFUAA SAAMAN KOODORU ,  RARII GURANTO KURISUUERU ,  RONARUDO RUISU TOOMASU

IPC: C07K16/00 ,  A23C9/142 ,  C07K1/34

Abstract: Disclosed are ultrafiltration processes for the enrichment and concentration of selected proteins from protein containing fluids. Illustratively, IgG is concentrated from whey by means of multiple ultrafiltration "passes", using a metallic oxide ultrafiltration membrane, which are characterized by differing pH's.

公开(公告)号：JPH02184633A

公开(公告)日：1990-07-19

申请号：JP30305589

申请日：1989-11-21

Applicant: ABBOTT LAB

Inventor： HAWAADO ROORENSU SHIYOU ,  JIEFURII ASUKANAJI ,  UIRIAMU DEII REZEMU

IPC: A61K38/00 ,  A61K9/10 ,  A61K9/107 ,  A61K31/20 ,  A61K31/23 ,  A61K31/66 ,  A61K31/685 ,  A61K35/54 ,  A61K36/48 ,  A61P31/12 ,  A61P31/18

Abstract: PURPOSE: To prepare a therapeutic agent for AIDS comprising an emulsion composition for parenteral administration containing specific amounts of soybean oil and an egg phosphatide. CONSTITUTION: This emulsion composition for parenteral administration comprises about 2-7wt.%, preferably about 2wt.% soybean oil and about 1-2wt.%, preferably about 1.2wt.% egg phosphatide. The composition has a higher ratio of the egg phosphatide/triglyceride than that of a commercially available lipid emulsion. Thereby, a sufficient level of the egg phosphatide can be provided to promote the mobilization of tissue cholesterol without causing the fat overload. The daily dose of the emulsion is within the range of 5-30mL/kg.

公开(公告)号：JPH02142786A

公开(公告)日：1990-05-31

申请号：JP24784189

申请日：1989-09-22

Applicant: ABBOTT LAB

Inventor： DANIERU CHINNUOU CHIYUU ,  ROBAATO HARASU

IPC: A61K31/00 ,  A61K31/435 ,  A61K31/47 ,  A61K38/00 ,  A61P31/00 ,  A61P31/04 ,  C07D401/04 ,  C07D471/04 ,  C07K1/113 ,  C07K5/06 ,  C07K5/08 ,  C07K5/10

公开(公告)号：JPH0276823A

公开(公告)日：1990-03-16

申请号：JP13295389

申请日：1989-05-29

Applicant: ABBOTT LAB

Inventor： POORU POOUEN HANGU ,  RANAJITSUTO ROIKOODOHARII ,  MAIKERU CHIENGUUIEN CHIEN ,  SHIYAUUGANGU RII ,  BERII JIYOSEFU RAZUKIN ,  UIRII YUUGEN SUKORENKU

IPC: A61K38/04 ,  A61K38/46 ,  A61P7/02 ,  C07H21/00 ,  C07H21/04 ,  C07K14/745 ,  C12N1/14 ,  C12N1/18 ,  C12N1/20 ,  C12N1/21 ,  C12N9/64 ,  C12N9/72 ,  C12N15/00 ,  C12N15/09 ,  C12P21/00 ,  C12R1/19 ,  C12R1/91

Abstract: PURPOSE: To obtain a thrombolytic agent comprising, as an active ingredient, a plasminogen activator protein product expressed by a polydeoxyribonucleotide segment coding a plasminogen activator protein and substantially having characteristics of urokinase. CONSTITUTION: This thrombolytic agent comprises, as an active ingredient, a plasminogen activator protein product expressed by a polydeoxyribonucleotide segment coding a plasminogen activator protein and substantially having characteristics of urokinase and has activities similar to that of naturally derived urokinase which is expensive in the production cost even when tissue culture is used. Furthermore, the active ingredient can be produced by a method similar to that of antibiotic compounds obtained by introducing modified plasmid in which a deoxyribonucleic acid coding a plasminogen activator concerning human urokinase is integrated into bacteria or other microorganisms and culturing these microorganisms.

公开(公告)号：JPH0232257A

公开(公告)日：1990-02-02

申请号：JP13251489

申请日：1989-05-25

Applicant: ABBOTT LAB

Inventor： NIIRU AASAA SHIIGERU ,  GURADEIMIIRU JIYOOJI JIYOOJIBU

IPC: C12Q1/28 ,  G01N21/78 ,  G01N33/52 ,  G01N33/72

Abstract: PURPOSE: To obtain a method and apparatus in which an indication coloring compound is fixed to a support and not leached or washed away by employing a coloring dye compound bonded covalently with a supporting matrix. CONSTITUTION: Second dye component bonded with a matrix is brought into contact with first dye component to produce a matter bonded covalently onto the matrix. A dye based second dye component is bonded covalently with a solid phase and when a liquid phase touches the solid phase, the second dye component is bonded covalently with an analyte or the first dye component proportional to the quantity of analyte to produce a coloring dye compound fixed covalently with the solid phase in proportion to the quantity of an analyte. Furthermore, the analyte in a test sample is determined qualitatively using an assay unit.